Peptides for Fat Loss: What Actually Works vs Hype (Recomp Guide)

"Peptides for fat loss" is a search that promises a shortcut: inject the right molecule and watch the fat melt while you keep — or even add — muscle. It's the recomposition dream, and an entire grey market exists to sell it. This guide does something the marketing won't: it routes you, peptide by peptide, through what the actual evidence shows, separates the one category with real human fat-loss data from the ones running on mouse studies and hope, and is honest about the fact that the most reliable "recomp" tool is still the one nobody's trying to sell you a vial of.

Honest headline first: there is exactly one peptide class with strong, randomized human evidence for fat loss — the GLP-1 (and related incretin) drugs — and almost everything else marketed "for fat loss" is either unproven in humans, a niche prescription drug for a specific medical condition, or a flat-out failure that the market keeps selling anyway. Worse, none of the popular "fat loss + muscle gain" peptides has shown true body recomposition — losing fat and gaining muscle — in a controlled trial of healthy, training people. Hold that frame as we go through the contenders.

First, the Inconvenient Truth About Recomp

Before any peptide, understand the physiology the marketing skips. Fat loss requires an energy deficit; gaining muscle is easiest in an energy surplus. Doing both at once — "recomp" — is genuinely hard and happens fastest only in specific situations (untrained beginners, people returning from a layoff, people with high body fat). For a trained athlete in a deficit, the realistic goal isn't gaining muscle — it's not losing it while you drop fat.

And the tool that actually protects muscle in a deficit is not a peptide. It's resistance training plus adequate protein. In trained athletes under caloric restriction, sufficient resistance-training volume is what spares lean mass¹, and the broader literature is consistent that exercise and protein intake are the levers that preserve skeletal muscle on a very-low-calorie diet². That's the boring, proven foundation. Any peptide is, at best, an addition to that — never a replacement for it.

The One Category That Actually Works: GLP-1 and Incretin Drugs

If you want a peptide with real, randomized human fat-loss evidence, this is it — and it's worth being precise about why. GLP-1 receptor agonists like semaglutide are peptides, and they produce large, well-documented weight loss in controlled trials. In the landmark STEP-1 trial, once-weekly semaglutide produced a mean body-weight reduction of roughly 15% versus placebo in adults with overweight or obesity³. That is real, replicated, regulator-grade evidence — a different universe from the animal data behind most "fat loss peptides."

But read the fine print for an athlete. These drugs work largely by suppressing appetite, so the weight lost includes a meaningful fraction of lean mass, not just fat — exactly what a physique- or performance-focused athlete is trying to avoid. They're approved for obesity and type-2 diabetes, not as physique-optimization tools for lean, trained people, and using them that way is off-label and carries real GI and other side effects. How much clinical wrapping comes with a compounded version varies enormously — Enhance MD bundles metabolic labs at Quest into onboarding and publishes a 40-state list, at the highest true month-to-month rate on either of our GLP-1 boards, while Queen RX sells a $299 flat quarterly purchase and names both its pharmacy (FootHills Pharmacy) and its separate prescribing entity (Beluga Health PC) in its own terms of service at a fraction of the price. Insurance handling is rarer still: Found Health works with insurance for both clinical visits and, per its own pricing page, the medication plan itself, but its advertised "$99/mo" headline requires a 12-month prepay — the plain monthly rate is $199 insured or $289 cash, confirmed live. Fitness RX bundles medication with fitness coaching and an app, but reveals the exact drug and dose only after an intake quiz, with no pharmacy or refund policy disclosed anywhere first, and Pomegranate Health confirms a real $119/mo price directly on its own product page yet names no legal entity, no address, and no pharmacy anywhere in its terms — a clean number sitting on top of almost nothing else. Citizen Meds confirms real sale prices directly on its own product pages, but names no legal entity and no address anywhere on the site, the identical gap. At the other end, Mixx Health and Wellness names a specific medical director, Dr. James David Lawrence III, MD, and a specific pharmacy, Promise Pharmacy, real disclosures none of the thin-information providers above bother with, and EverSlim names three specific pharmacy partners and a named medical group, DrTelx, rather than a generic claim, a similar depth. Alternate Health Club splits the difference: a specific, checkable LegitScript ID, but no legal entity name, address, or pharmacy anywhere in its own policies, and HelloWellness confirms real starting prices directly on its own pricing page, but names no legal entity, address, or specific pharmacy anywhere, the same shape a third time. BlisMD confirms a real $109/month price directly on its pricing page, but names no legal entity, no address, and no pharmacy anywhere, and NuviaRx names a real entity at a printed street address that turns out to be a USPS post office's virtual-mailbox suite, not an operating clinic. Care Clinics itemizes real package prices with medication included, but names no legal entity, address, pharmacy, or refund policy anywhere, while Aquivia Health names a real Chief Medical Officer, Steven Bishop, MD, though its annual prepay pricing doesn't cleanly reconcile with its own stated monthly rate. Dr. Gillis Wellness Center names a real, board-certified physician with 25+ years of experience and a real $149/mo starting price, but no pharmacy, LegitScript status, or refund policy anywhere in the sources read. Heva Health bundles a genuinely distinctive 91-biomarker lab panel into its offer, but names no legal entity, state of incorporation, or pharmacy anywhere in the sources read. Trinity Meds names both its operating entity, Trinity Meds Inc, and its clinical partner, CareValidate Health, real disclosures a Shopify-hosted competitor skips entirely: PlexusDx's storefront displays no logo of its own anywhere on the page, only other brands' marks and product photography. A headline price is only the whole story if the real one is disclosed nearby: Heros Health advertises "from $119/mo," but the price a first-time customer actually pays is $149 the first month and $199 ongoing, confirmed live, on a site whose own coverage claims disagree with themselves ("50 States" in one section, "46 States" in another). A publicly traded parent is real credibility, but it doesn't simplify the bill: Hers, the women's brand of NYSE-listed Hims & Hers Health, charges a $39-then-$149/mo membership that doesn't include the drug itself — medication is billed separately, from $149 to $1,899/mo. And a headline offer only means something if it's explained: InstaRX's "Get Started For Just $199" matches neither its $179/mo semaglutide nor its $259/mo tirzepatide price, and the site never clarifies what the fee actually buys. Not every site can even be checked: Liberty blocked every fetch attempt on this pass, and a secondary source describing 47-state coverage contradicts prior research's "all 50 states" claim, a gap this review flags rather than papers over. And a homepage number is worth reading against the fine print underneath it: Lttl's "Plans start at $129/mo" is a 12-month prepay rate, confirmed live — true month-to-month is $199 for semaglutide and $279 for tirzepatide. Three different pages quoting three different numbers is its own kind of red flag: Layla's own site can't agree with itself on the ongoing price for compounded semaglutide — $199, $237, or $297/mo depending on which landing page a visitor arrives through. Real infrastructure doesn't always come with real pricing transparency: Medi-Weightloss runs 139 physician-supervised locations nationwide, confirmed live, but its own pricing page directs readers to call an individual clinic rather than publishing an ongoing monthly rate. Not every provider can even be checked: Medro blocked every fetch attempt on this pass, and a broader search turned up almost no independent coverage at all, consistent with a very new 2026 brand. And a broad marketing tone can hide a narrow real footprint: Neo Soma Healthcare's own FAQ states it currently serves Texas only, a real correction to an earlier finding of no published state information at all. A "starting at" number tied to one specific drug is easy to misread as the whole menu's price: Options Medical Weight Loss's $199 semaglutide figure doesn't apply to tirzepatide, which starts at $299 on the same site. A named pharmacy is real transparency, but it isn't the same as a flexible policy: PauseRX names Rush Pharmacy outright, confirmed live, while its own FAQ states orders can't be changed or canceled once submitted, full stop. And a price can climb without your dose ever changing: Recovery Delivered's compounded semaglutide rate rises automatically the longer you stay on the program — from $199.99/mo to $299.99/mo by month five — regardless of your prescribed dose. Committing to a full year is one way to get the lowest published rate: REMEVi's $149/mo semaglutide figure requires a 52-week plan, confirmed live — month-to-month runs $219/mo instead. A flat monthly figure can hide a separately billed medication cost entirely: Rex MD's program fee starts at $75/mo, but brand-name Wegovy is billed separately by the manufacturer at $499/mo, confirmed live. And a footer that looks like a legal page isn't always one: Ryze Rx's Privacy Policy, Terms of Service, and HIPAA Notice were never coded as real links at all, confirmed by inspecting the site's own source. A GLP-1-specific claim doesn't always match a site's broader catalog: SkyRx's own weight-loss pages say GLP-1s "are not yet available in all 50 states," a different claim than a separate general FAQ elsewhere on the site. A finished-looking site can still ship an unfinished legal document: [Spry's own Terms and Conditions PDF still reads "[Insert Your State]" where its governing-law clause should be, confirmed live](/reviews/spry). And a published price ladder is worth reading dose by dose: StackMD prices tirzepatide from $199 to $449 depending on strength, confirmed live, while stating plainly it has no authority to issue refunds on its prescribing partner's behalf. A solo-physician model is checkable in a way a rotating clinician pool isn't: TOM Weight Loss's named physician, Dr. Tran Le, has an NPI independently confirmed Active in the federal registry, confirmed on this pass. "Physician-led" is a claim worth checking against who's actually named: Vitalex Health repeats that language throughout its site, confirmed live, though no clinician of any kind is named anywhere, and its /about and /our-team pages both return 404. And a banner price is only the whole story if it matches the checkout: Arc-1 advertises "starting at $149.99/month," confirmed live, while its own product data shows a real floor of $199.99. Not every listing on this site is still a GLP-1 provider today: Rebody Health has pivoted entirely to peptides and NAD+, confirmed live, with zero mention of semaglutide or tirzepatide anywhere on its current site. A clean headline number doesn't always survive checkout: LifeRx.md advertises "$200, no hidden fees," confirmed live, though independent reporting and a pattern of BBB complaints suggest shipping, consult, and follow-up fees stack on top. And a rare inclusion is worth reading carefully: Optimized Health's own language describes labs as included "when clinically indicated," confirmed live — a conditional promise, not a flat guarantee. Injectable and oral formats aren't always priced the same: Fitish offers both, confirmed live, alongside a genuinely separate, lower-priced microdosing tier distinct from its standard 28-day supply. A firm flat number can still sit inside a platform built around something else entirely: TRT Nation prices tirzepatide flat at $219/mo any dose, confirmed live, though GLP-1 remains secondary to its core testosterone-therapy business. And a site that won't load is its own kind of finding: FMmeds returned no server-rendered content across every fetch attempt this pass, leaving prior research's aggressive "$95/mo" pricing claim unconfirmed. Four broken pages is a pattern, not a coincidence: Tonik Wellness's FAQ, how-it-works, shipping, and contact pages all return 404 errors, confirmed live, on a site whose semaglutide product is also currently out of stock. A clinic can be genuinely credentialed and still avoid naming the drug it prescribes: Onyx Weight Loss's treatment pages never say "semaglutide" or "tirzepatide" anywhere, confirmed live, using only generic "GLP-1 Agonist" language instead. And a real pharmacy partnership doesn't rule out a shared backend elsewhere: AVARA Rx names its pharmacy and clinical network outright, confirmed live, while its registered address matches the exact Sheridan, WY suite already documented behind two other storefronts on this site. An intro rate assumes you'll stay past the intro period: Transparent Meds prices semaglutide at $99/mo intro, confirmed live, before it steps up to a $229/mo list price. A celebrity founder is a real fact, and so is a federal warning letter: Good Girl Rx, founded by Savannah Chrisley, received an FDA warning letter dated 2026-02-20 for marketing language overstating its compounded products' FDA approval status, independently confirmed. And a headline price only tells the whole story if it's the flexible rate: PepHaus advertises tirzepatide "from $245/mo," confirmed live, but that figure is the 6-month prepaid tier — the flexible monthly rate runs $289/mo instead. None of it changes what the drug was approved to treat. The newer triple-agonist retatrutide pushes weight loss even further in trials, but it's investigational and the same lean-mass and off-label cautions apply — we cover that specific case in our review of retatrutide for athletes and body recomposition. Bottom line: this category genuinely works for fat loss, but "works for weight loss in obesity" is not the same as "the right recomp tool for a lean athlete."

That lean-mass caveat now has hard numbers behind it. A 2026 systematic review of 35 randomised body-composition trials found the median proportion of total weight loss coming from muscle-based indices was 28.3% in the incretin arms — with the honest counterpoint that a substantial share of the lifestyle and placebo comparators exceeded their benchmark too, and that no included study measured physical function. We work through what that means for anyone who trains in peptides for weight loss and muscle gain. And if the question has moved from whether to which vial — approved product, compounded prescription, or a research-use-only vial from a website — the differences are measured rather than administrative, and we lay them out in peptide injections for weight loss.

The GH-Axis Peptides: Real Drug, Narrow Use, Oversold Everywhere Else

The growth-hormone-axis peptides are where the fat-loss marketing gets loud. The honest evidence splits sharply.

Tesamorelin is the one with genuine human fat-loss data — but for a specific population and fat depot. It's an FDA-approved GHRH analog shown in randomized trials to reduce visceral abdominal fat in HIV-associated lipodystrophy⁴. That's a real, approved effect — but it was demonstrated in a clinical population for a particular kind of fat, not as a general physique-leaning tool for healthy athletes, and the visceral-fat reduction tends to reverse when the drug stops. We dig into what that does and doesn't mean for athletes in our review of tesamorelin for athletes.

The rest of the GH-secretagogue family — sermorelin, CJC-1295, ipamorelin, MK-677 — is sold hard for "fat loss" on the theory that more growth hormone means more lipolysis. The biomarker logic is real; the body-composition payoff in healthy, training people is not demonstrated. When GH itself was tested rigorously, it changed body composition partly through fluid retention without delivering functional benefit, and the secretagogues that nudge your own GH up modestly have no controlled trial showing they strip fat in healthy athletes. MK-677 (ibutamoren) is a cautionary case: it reliably raises GH and IGF-1 but is associated with increased appetite and water retention — the opposite of a clean fat-loss profile — which we detail in our MK-677 evidence review. For the broader GH-axis muscle-and-leanness story, see how the GH-axis peptides grade for muscle and sermorelin for muscle growth and bodybuilding.

The "Fat Loss Fragment" That Failed: AOD-9604 and HGH Fragment 176-191

No peptide is marketed more directly "for fat loss" than the growth-hormone fragments — AOD-9604 and the closely related HGH fragment 176-191. The pitch is elegant: a fragment of growth hormone engineered to deliver GH's fat-burning (lipolytic) effect without the side effects.

Here's the part the marketing buries: AOD-9604's large human obesity trial reportedly failed to beat placebo for weight loss, and its development as an obesity drug was halted. The lipolytic story is genuine in cells and animals, but the controlled human trial — the only thing that matters — did not deliver. We lay out that failure in full in our review of AOD-9604 for fat loss, and the near-identical evidence gap for its cousin in our HGH fragment 176-191 evidence review. A peptide whose flagship human trial flopped is not a fat-loss solution, no matter how good the mechanism sounds.

The "Recomp" and Metabolic Peptides: Promising Biology, No Human Recomp Trial

Then there's the category sold specifically for the recomp dream — losing fat and gaining muscle. MOTS-c, the mitochondrial "exercise mimetic," has striking metabolic and endurance data — entirely in rodents, with no human performance or fat-loss trial, as we cover in our MOTS-c endurance evidence review. The same pattern repeats across the metabolic-peptide space: interesting animal biology, an absent human recomposition trial. No peptide has been shown in a controlled trial to simultaneously strip fat and add muscle in healthy, training adults. When a vendor sells you a "fat loss and muscle gain" peptide stack, they're selling you a hypothesis, not a result.

The Legal, Quality, and Anti-Doping Reality

Most of the peptides above (the GH-axis compounds, the GH fragments, MOTS-c) are not FDA-approved for fat loss and are sold "for research use only" by grey-market vendors — meaning unverifiable identity, purity, concentration, and sterility, a real safety problem on top of weak efficacy. The prescription exceptions (GLP-1 drugs, tesamorelin) are real medicines for specific approved indications, and using them off-label for physique goals is a decision for a clinician, not a vendor. It is also a decision the compounded-GLP-1 sellers make oddly hard to cost out: Oak Longevity runs a "one price, all dosages" banner above three different, unreconciled semaglutide figures on its own pages, and Embody markets its $79 rate as "locked forever" while its own terms separately state a $199 list price for the same product, a third number that matches neither the promo nor the store's own $299 struck-through anchor. Gala Health footnotes its own $179 a month as a figure calculated on a yearly subscription, with no single-month rate published anywhere. Potere Health MD does the same division at a shorter interval — its "~$80/month" is a single $239.99 charge for a 12-week fill, split three ways, with no month-to-month option behind it. TRYM Health skips the monthly figure entirely and prices everything per day instead — "as low as $3.20/day" for semaglutide — leaving the reader to multiply by 30, and Green Cap Health does the same thing with "from $2.63/day," which is really a $79 first-month promo ahead of a higher ongoing rate. MANU Telehealth prices GLP-1s "from $4/day" to "from $5/day" rather than a monthly figure, the same pattern a third time on this list, and HeliMeds runs the same trick by the week instead — "Get GLP1+GIP for $37.25/week," which works out to roughly $161 a month, higher than the flat $149/month starting-dose figure an earlier capture of this row recorded. CoraDoc's "starts at $99/month" is real, but it is the 6-month-commitment tier; its own FAQ shows the 3-month starter at $165/month and 3-month maintenance at $199, 65 to 100 percent above the headline. Fidelity Medical Clinic's cheapest figure is a one-time, two-month "Initial Prescription"; every prescription after it — the rate a continuing patient actually pays — is $199, roughly double. Southern Vitality and Weight Loss leads with "GLP-1 from $99/mo," and its own FAQ states that's a 3-month prepay — month-to-month is $199 for semaglutide and $299 for tirzepatide. Prices also just go stale: Jyra Health's semaglutide page reads "from $139/mo" in its own title tag today, well above the $99 a prior capture recorded, a reminder that a provider's number is only as current as the last time someone actually read the live page. 10Rx's dedicated pricing page doesn't even render a dollar figure into fetchable HTML — the specific rate loads from a script — so a stale number can sit unnoticed for even longer than usual before anyone catches it, and Trillium Meds renders none of its pricing into fetchable HTML at all — the homepage is almost entirely a client-side JavaScript shell, the same gap one step further. Zeuss's own pricing page did not render a dollar figure into this pass's fetch either, despite an earlier capture recording a figure around $125, and Bioverse advertises "transparent pricing" while no specific dollar figure for semaglutide or tirzepatide rendered anywhere on the pages read — the exact word most providers on this list are careful not to use. Livv's own homepage advertises "3 simple, flat-price plans" without ever stating what those flat prices actually are, the same pattern once more. Prepay tiers hide a different number: Lavender Sky's own site advertises "from $95/mo," but that figure requires a 2-month prepay, and a true month-to-month plan exists at only about two of the roughly ten pharmacies in its network, and Cielo Health advertises "From $89/Month," a figure that requires a 6-month plan; the standing month-to-month rate is $199, more than double. Center for Medical Weight Loss runs the identical shape: its largest-type "$116/mo" hero price is the 3-month-plan rate, with the real $149/mo month-to-month figure printed in smaller struck-through text right beneath it. MediRX's own 6-month-plan pricing card goes further still: its largest-type "$70" first-month price sits above a smaller "$239" printed as the "after" rate on the very same card, a more than threefold jump disclosed on the card but not in the headline figure. Ondra Health takes the opposite approach to trust-building — five named prescribing physicians and five named pharmacy partners — though one of those five pharmacies is quietly excluded from nine states despite an advertised all-50-states banner. Precision Telemed skips the prepay-tier games entirely — a flat $149/month for semaglutide, month-to-month, no subscription required, a simpler structure than several sibling providers on this list use. Tyde Wellness's five named pharmacies come without a corporate address or medical director attached, while Zera Health names one pharmacy, Strive, and discloses honestly that its compounded drugs are not FDA-approved rather than claiming otherwise. Youth and Soul's own copy makes the opposite claim outright — "FDA-Approved Compounds" — per an earlier capture of this row. Wholesome Clinic's genuinely low $109/mo oral price sits alongside separate evaluation and follow-up fees not folded into the headline, and Zappy Health's flat, dose-independent pricing carries a 9-month commitment to reach its lowest advertised rate. ZYP Medical's $50 initial consultation is one of the lowest entry costs on this list, though it doesn't name a compounding pharmacy behind it. LevelUp Rx names two dispensing pharmacies but no single medical group covering the states it serves beyond four, LevelsRx advertises a money-back warranty with no spelled-out qualifying terms, and NP2GO publishes its complete per-dose pricing matrix openly while naming no compounding pharmacy at all. LeanDose's advertised $159 price is explicitly a first-month rate — the site's own copy warns the ongoing cost may be higher without stating what it becomes. Effecty's brand-name Ozempic and Wegovy path carries no discount at all — full retail, $1,300 to $1,600 a month, the same price as buying it anywhere else, while Remote Pharmacy's genuinely no-fee structure means a reader pays only for the medication itself, with the consult and shipping both free. Actin's $116/mo headline requires a 6-month plan, with the real month-to-month rate at $169, and MyFastRx's advertised $99/mo goes further still, requiring a full 12-month prepay against a $169/mo standard rate. Bon Health's $170/mo requires an annual plan too — month-to-month is $330, nearly double. Luma Health Co is founded by a named nurse practitioner and prices transparently with no subscription, but also sells investigational retatrutide under the branded-sounding name "RTT (GLP-3)". PeptidesRx positions itself explicitly against gray-market research-chemical sellers with a named medical director, though its own compounding pharmacy is never named. Amble's homepage promo hides a $79/mo gap between the banner price and the standard starting-dose rate, and AbundRX's own text claims LegitScript certification with no seal a reader can actually check. Bodi Envi's own site was rate-limited on every fetch attempt this pass, so its founder background and flat pricing rest on prior research not independently reconfirmed. ElixaMD's own $179 headline is a first-month rate, ongoing cost tiers to roughly $249-$299, and Eloria's brand-name Wegovy path adds a separate $99/mo membership on top of the medication cost. Intimate Rose's own site was rate-limited on every fetch attempt this pass, so its $169/mo published price rests on prior research not independently reconfirmed. YourHealthRx claims "transparent sourcing" while naming no compounding pharmacy, and its headline price is a first-month intro rate rather than the roughly $170-$210/mo it actually costs ongoing. TrueMe's flat price is genuinely all-inclusive, but bills every 4 weeks rather than the calendar month it markets against, and Vita Bella's advertised medication price sits behind a separate $129/mo membership most readers won't see until checkout. Tuyo Health names its founding physician, Dr. German Echeverry, and bundles lab work into an all-inclusive $155/mo price, a real disclosure Injectco's bulk pricing skips entirely, alongside never stating which drug that price actually buys. Coby Health names a clinical network, Beluga Health P.A., but its tirzepatide pricing more than doubles by the 15mg dose. The major-brand channels aren't exempt from the same headline-vs-real gap: Ro's Foundayo price bills the drug and a recurring membership separately, Amazon One Medical's cheapest Foundayo rate needs insurance plus a coupon stacked together, GoodRx never prescribes anything itself, only discounts a prescription you already have, LillyDirect's savings-card rate excludes Medicare and Medicaid entirely, and PlushCare's GLP-1 access is a clinician-discretionary outcome of a primary-care visit, not a guaranteed prescription at signup. Two of the tidier-looking pricing pages simply split the bill in two instead: Primary Clinic's $89 monthly membership buys unlimited care and no medication at all, with the compounded GLP-1 charged on top and climbing across four dose bands, and Ivím Health prints "starting at $75/mo" directly above a separate "+ $74.99/mo Program Fee" on the same panel. At least those two eventually name a drug price — BodyLogicMD advertises a "$79 Monthly Plan" across its own homepage and pricing page and never states a medication cost at all, for GLP-1 or its core bioidentical-hormone product, anywhere on the site. PreventiveMD splits the bill a third way: its compounded semaglutide is one all-in figure, but its brand-name Wegovy and Zepbound path adds a separate $49-a-month membership fee on top of the medication cost — two pricing structures on one platform, not one. Wisp's "$99/month" buys the consult for its brand-name path (Wegovy, Zepbound, Saxenda); the drug itself is billed separately at pickup or checkout, the same split, on medicines that are not cheap to discover the real cost of after the fact. Measured's "$79/mo" headline is real for one microdose tier, but the platform's actual brand-name Wegovy and Zepbound business runs $149 to $449 a month plus a separate membership fee, a wider gap than the entry price alone suggests. Against that backdrop, Belle Health's flat rate holds across every dose band with no escalation as the dose increases, and dose increases, nutrition guidance, and nurse support come bundled in at no extra cost — the kind of pricing structure that's simple enough to require no splitting-in-two at all. Some pricing pages skip the number entirely rather than hide it in a gap: Florida Weight Loss MD publishes only a $99 consult fee ($49 applied to the program); the actual monthly medication cost isn't disclosed anywhere on the site until after the evaluation. And sometimes the pricing page is the least of it: GOAL.MD's own homepage currently serves a "Website Takedown Notice" in place of any storefront at all, on a provider whose co-founder and chief physician separately carries a 2016 federal guilty plea for distributing misbranded HGH, a reminder that a struck-through price is a minor problem next to a site that's not even live. A membership fee and a medication price are not the same line item, and it's worth checking which one a headline is actually quoting: Allara Health's $149/mo Complete Care Program price is confirmed live on its own pricing page, but that figure covers the care team and labs — the GLP-1 medication's own cost isn't published anywhere on the same page. A bundled "value" stack is worth pricing skeptically, confirmed live: OrderlyMeds' $74/mo semaglutide intro rate rises to $149/mo after month one, alongside extras marketed with inflated dollar figures — a '$648 value' webinar series among them — that read more like padding than real savings. Silhouette MD's semaglutide entry price is competitive, per prior research, but tirzepatide and its oral options both run above many compounded rivals on this board, and JustAnswer Weight Loss's roughly $150/mo figure is genuinely the only detail prior research could confirm — the live site renders no further pricing data to fetch. A commitment length can hide behind a monthly-sounding headline, confirmed live: OnlineSemaglutide.org's "From $150/month" semaglutide price is explicitly a 6-Month Plan rate, with no shorter or month-to-month figure published anywhere this pass could find, and Alan Meds' "$158/mo" headline is paid upfront as a 2-month plan, per the site's own asterisk, shown beside a struck-through "$315" with no stated explanation of what that figure represents. Some sellers skip publishing a price at all: Medivive discloses its monthly cost only after an AI-guided intake and optional at-home labs, per prior research, so there's nothing to compare against a competitor's headline before starting that process. And a headline can lead with insurance rather than a cash figure, confirmed live: Nurx's own homepage advertises weight-management treatment "as low as $0 with insurance" rather than stating what a self-pay reader would actually owe. A 12-month plan can hide behind a monthly-sounding number too, per prior research: Roboclinic's $179/mo compounded semaglutide requires a 12-month plan — month-to-month runs $299/mo, nearly double, and RxSaludable's $99 first-month price reverts to $179/mo after, roughly 80% higher, on an otherwise genuinely distinctive Spanish-language platform. A headline figure and the actual page can disagree in more than one direction: Vytora Health's marketing copy leads with "from $149/mo," confirmed live, but that figure needs a 3-month prepay — the real 1-month price on the same page is $179/mo, and Whoosh Wellness's pricing-page meta description advertises "$133/mo" while the pricing card rendered on that very page shows $149/mo as the lowest tier. Even the underlying research can disagree with itself: HealthOn's own prior research recorded a $189/mo figure tied to a 12-month plan in one place and "$155/month" in separate descriptive text elsewhere, a gap not resolved on this pass, and Navio MD's $189/mo headline is real but is specifically the lowest-dose price, confirmed live, climbing to $247/mo or higher on higher doses. A quarterly plan can lower the effective monthly rate honestly, as long as the standing rate is stated too: Somira Health's $136.66/mo figure requires paying $409.99 upfront for a quarter, confirmed live — the standing month-to-month rate is $189.99/mo, and Welling Health's "as low as $133/month" streak-discount price, confirmed live, reverts to the full $190/month rate the moment a day of meal-logging is missed. A promo mentioned in prior research isn't always still findable on a later pass: Lumen Meds' prior-research $0 first-month promotional price didn't turn up anywhere in this pass's fetch, worth confirming directly before assuming it still applies, and TeleZen MD offers "$100 off your first order," confirmed live, on a site that never states what the steady-state price actually is. BetterMe Rx's $199/$299 headline prices, per prior research, are limited-time sale rates against $249/$349 regular ones, and BloomWell Rx's $199/month semaglutide price, confirmed live, is a "starts at" figure — final cost depends on the dose and plan you choose. Curex's "$49 first month" promotion, confirmed live, reverts to a $199/mo standing rate, and DrMedHealth backs its $199 semaglutide price with real, structured Product schema data, confirmed live. Go Vida Plena's "$179/month" figure, confirmed live, is specifically an annual-plan rate rather than a standing monthly one, and Heally prices semaglutide "From $149/mo," confirmed live, across a genuinely broad menu of individually-priced longevity and hormone options. A named pharmacy is a real positive, even alongside a gap elsewhere: Elara MD names Strive Pharmacy in Gilbert, AZ with a full address, confirmed live, yet its homepage, FAQ, and Terms of Use never once name semaglutide or tirzepatide, using only "Personalized GLP-1" throughout. Indexed content can correct a flat-rate assumption: Independent Wellness's own robots.txt blocks automated research crawlers by name, and the search-indexed content that remains shows tirzepatide priced separately and higher than semaglutide, not the single flat rate prior research recorded. And a widely-repeated stat is worth checking against the actual site quoting it: Luma Meds' commonly-cited "100,000+ members treated" claim doesn't appear anywhere on lumameds.com's homepage, FAQ, or Terms of Service, confirmed live — that figure appears to actually belong to a similarly-named competitor, LumiMeds. A four-pharmacy network is a real transparency signal, even without a maintenance price attached: OnlyRx names four compounding pharmacies with phone numbers and four prescribing physicians, confirmed live, though the site never states an ongoing rate beyond a "starting at" figure. And real pricing doesn't always come with a real name behind it: Open Water Rx discloses genuine per-drug pricing and 50-state coverage directly in its page source, confirmed live, but names no compounding pharmacy, physician, or legal entity anywhere on the site. A named medical director is a real disclosure worth checking against the rest of a site's transparency: WePeptideRx names Medical Director Hridyesh Nat, MD, and an itemized 48-state coverage map, confirmed live, though its compounding pharmacy is still never individually named. And an "$83/mo" headline deserves a second look at the fine print: WeightRx's tirzepatide price is really a $997 annual prepay divided into a monthly-sounding figure, confirmed live and corroborated by a refund policy stating 6- and 12-month plans are non-refundable. A detailed refund policy is worth noticing when most competitors settle for one blanket clause: Fitstry offers three separately named guarantees in its refund policy, confirmed live, though its compounding pharmacy is still never individually named anywhere on the site. And named pharmacies are worth less without a findable policy page to back them up: Premium Health names three real compounding pharmacies, confirmed live, while its dedicated pricing, membership, and refund-policy URLs all return 404. An honest narrow footprint beats an inflated nationwide claim: LIV by WellNow serves only five states — Pennsylvania, New York, Illinois, Indiana, and Michigan — per an archived snapshot of its own site, rather than overselling broader reach. And a discounted first month is worth reading against the commitment behind it: Society of You's refund policy states, verbatim and confirmed live, that the first two months of any plan are non-refundable under any circumstances short of medical disqualification. A regional urgent-care brand's telehealth arm is worth confirming your location against, not assuming: VirtualCare2Go's cancellation policy states plainly, confirmed live, that a confirmed visit becomes non-refundable — a stricter line than the general FAQ's 24-hour window suggests. And a $10 cancellation fee is a genuine rarity in this category: Emerge Weight Loss charges only a $10 refund fee if you cancel before your order reaches the pharmacy, confirmed live, well below the blanket "all sales final" policies most compounded-GLP-1 competitors use. Unlimited visits and included labs are worth more when the product itself is fully disclosed: Apex MD bundles unlimited provider visits and Labcorp labs into its price, confirmed live, though its "LegitScript Certified" claim is a generic icon rather than a real, checkable seal. And a scale claim repeated often enough starts to sound like proof, even when it isn't: Freya Meds' homepage states "450,000+ patients across 50 U.S. states" six separate times, confirmed live — a figure this pass couldn't independently audit against any outside source. Named clinicians are worth more when the trust badge next to them actually checks out: Claya names two licensed clinicians and two compounding pharmacies with full addresses, confirmed live, though its "LegitScript Certified" badge doesn't link to legitscript.com anywhere on the site. And free coaching is a real perk, but it doesn't substitute for a published price: Fella Health includes free 1:1 health coaching with its membership, confirmed live, though the core GLP-1 monthly price is never stated anywhere beyond a vague "under $10 per day" figure. A shared clinical-partner name is worth noticing across storefronts you might assume are independent: Lumora's founding physicians both practice under Arora Health & Aesthetics, confirmed live, the same clinical-partner name independently confirmed elsewhere on this site behind EOS Health. And a similar name is worth double-checking before you commit: Mint Medical Clinic is a genuinely separate, Utah-only med spa, confirmed live, easily confused with Mint Med, a different, LegitScript-certified national platform reviewed elsewhere on this site. A named physician is real, checkable credibility, even alongside a network worth knowing about: RestorLife Med names a board-certified founding physician licensed in all 50 states, confirmed live, though its own Terms name Beluga Health, P.A. as the entity actually providing care, eight separate times in the document. And a launch discount is worth reading against the price it reverts to: SnagRx's $69/mo semaglutide launch price, confirmed live, reverts to a standard $299/mo — more than four times higher. An early-termination carve-out is a real courtesy in a category full of hard commitments: tru Weight Loss requires a 3-month subscription before standard cancellation, confirmed live, but explicitly allows early termination if you don't tolerate the medication. A legal entity and a drug identity can both be real without appearing on the homepage: Velvet Rx's oral GLP-1 product is confirmed live as compounded semaglutide, and its operating entity, Rocket Health Inc., is named in its Terms of Use — neither shows up on the homepage itself. And a first-month promo isn't the same thing as an ongoing price: AquaVita NextGen publishes only a $375 first-month semaglutide rate, confirmed live, with the ongoing monthly price — and all tirzepatide pricing — never published anywhere. A named, board-certified founder is worth more when the site's own legal pages back it up: Gaya Wellness names a single OB/GYN founder, confirmed live, though no Terms of Service, Privacy Policy, or Refund Policy exists anywhere on the site. And a homepage banner is only as honest as the price it actually leads to: Lemonaid Health advertises "GLP-1s starting at $129/mo," confirmed live, though the lowest combined figure found anywhere on the site works out to roughly double that. The manufacturer's own program still requires a prescription from somewhere else: NovoCare Pharmacy, Novo Nordisk's own Wegovy channel, includes no telehealth intake or clinical support of its own, confirmed live — you need an outside prescriber either way. And a named pharmacy network doesn't guarantee a polished site behind it: [Revive Meds names six compounding pharmacies and four physicians, confirmed live, though its own About page still contains unfilled "[Image Prompt]" placeholder text live on the production site](/reviews/revive-meds). A named physician network is worth more than an anonymous provider pool, even if no individual is named: TeleDocs360 discloses that care is provided through Impact Health, a named physician network, confirmed live, alongside the clearest, plainest-language refund terms found in recent batches. And a real, checkable credential is worth more than a marketing claim: Garcia Weight Loss's medical director, Dr. Rufus Armstrong, MD, independently checks out as a real, active physician against the federal NPI registry, confirmed live, though no price for its GLP-1 program appears anywhere on the site. Language access shapes who can actually use a program: Mojoon is the only bilingual Mandarin/Cantonese GLP-1 telehealth platform found in recent research, confirmed live, pricing tirzepatide clearly by dose tier at $390–$490/month. Not every telehealth platform fills your prescription itself: Push Health writes GLP-1 prescriptions but doesn't dispense medication, confirmed live — you coordinate fulfillment directly with whichever pharmacy you choose. Insurance coverage changes the math entirely: Form Health bills GLP-1 care through private insurance and Medicare rather than cash pay, confirmed live, with a $299/month self-pay option that covers clinician visits only, not medication. Bundling labs with prescribing is a different model than most: 1st Optimal pairs GLP-1 prescribing with at-home labs and blood-work interpretation, confirmed live, though no price appears anywhere until after a quiz or consultation. Real insurance billing changes the math for weight loss too: Ascend Medical bills GLP-1 care through insurance as one line within a broader primary care practice, confirmed live, starting at $150 — though it currently serves only Georgia and Texas residents. Offering both compounded and brand-name options on one platform is genuinely rare: Aspire Health prescribes compounded semaglutide/tirzepatide or brand-name Zepbound and Wegovy side by side, confirmed live, backed by a real, domain-matched LegitScript seal. A broader metabolic framing is a different pitch than a single drug: Basal Health frames GLP-1 therapy around five metabolic markers rather than one number on a scale, confirmed live, with a real $99 first-month tirzepatide price published plainly. Published pricing is still rare enough to be worth noting: Better MedSpa lists a real tirzepatide starting price on its own site, confirmed live, from a medical director independently confirmed active via the federal NPI registry. Itemized pricing embedded right in the page is worth noticing: Brello Health publishes exact tirzepatide and semaglutide prices directly in its own site data, confirmed live, backed by a genuinely verified LegitScript seal. Published pricing plus a full state list is rarer than it should be: CaliberRx prices both compounded drugs at a flat $199/month, confirmed live, with a complete 46-state coverage list and a genuinely verified LegitScript seal. A findable visit fee is worth more than a vague "contact us": Call-On-Doc prices its GLP-1 visit at a real $75, confirmed live, backed by a genuinely verified LegitScript seal. Choosing between a compounded and a brand-name path is a real decision worth pricing out: Chronos Body Health and Wellness prices both paths clearly, confirmed live, from a founding physician independently confirmed active via the federal NPI registry. A named prescriber with a genuine obesity-medicine credential is worth more than an anonymous provider pool: Dollar Dad Club's lead physician, Dr. Jeffry Shellenberger, independently checks out as real and active with a dual Emergency and Obesity Medicine credential, confirmed live. Real, published tiered pricing is worth something even when the legal pages need work: Eclipse Medical Wellness prices its 3-month starter program at a flat $500, confirmed live, from a nurse practitioner whose phone number matches her own NPI record exactly. An employer-benefits integration is a different access model than typical cash-pay telehealth: eMed's historical model paired at-home blood collection with a $99/month program fee and direct CVS Caremark benefits integration, per a 2023 archive, though its live site currently blocks verification of whether this still applies. Real, repeated outcomes data is worth more than a marketing claim: Enara Health publishes the same 22% average weight loss at 18 months figure consistently across its site, confirmed live, backed by a roster of roughly 25 named clinical providers. Three named physicians who all independently check out is real transparency: Evolve Telemed's three named prescribers — an MD, a DNP, and a second MD — are all confirmed real and active via the federal NPI registry, confirmed live. A recognized name in obesity medicine adds real weight to a clinical roster: FlyteHealth's Chief Scientific Advisor, Dr. Louis Aronne, is a well-known Weill Cornell obesity-medicine researcher, confirmed live, alongside three more named MDs in leadership. A real, NPI-verified Chief Medical Officer backs a genuinely broad menu: Genesis Lifestyle Medicine's Dr. Alex Spinoso independently checks out as active via the federal NPI registry, confirmed live, overseeing both brand-name and compounded options across 18 physical clinic locations. Real pricing across most of a menu is worth something even when one path hides a fee: Good Life Meds publishes exact prices for compounded semaglutide and tirzepatide, confirmed live, backed by a named pharmacy and a genuinely verified LegitScript seal. Not everything marketed for fat loss is a GLP-1 at all: AmberHealth sells an over-the-counter hops-extract capsule called "GLP-1 Natural Support," confirmed live, with its own FDA disclaimer stating plainly it isn't intended to diagnose, treat, cure, or prevent any disease — not semaglutide, tirzepatide, or any prescription medication despite the name. And a landing page can undercut its own credibility with basic arithmetic: Iron Med Rx's own GLP-1 page claims "10,000+" patients in one section and "500,000+" in another, confirmed live, alongside a leftover header still referencing a different brand entirely, "Peptela". A monthly program fee is not the same thing as a monthly total: JM Integrated Health's $99/month program fee, confirmed live, doesn't include GLP-1 medication at all — that's billed separately by an unnamed compounding pharmacy that only reaches out after enrollment. And a discounted intake fee can still hint at what pricing looks like behind the phone call: JumpstartMD advertises its first visit at "$99 ($379)," confirmed live, while its ongoing program pricing is never published anywhere and is available only by calling. Sometimes a site simply won't let you check the price at all: LifespanningRx's own FAQ, Licensing & Compliance, and pricing collection pages were all rate-limited across repeated attempts, confirmed on this pass — its most basic pricing claim couldn't be independently confirmed. And a marketing claim is worth reading against the FAQ underneath it: MD Trim Clinic's FAQ calls its compounded medications "this new FDA-approved medication" in one place while describing them elsewhere as custom-blended compounded formulations, confirmed live — the drug class is FDA-approved, the compounded product itself is not. Not every provider leads with weight loss even when it prescribes GLP-1s: MEDVidi's own homepage title reads "Online Mental Health Care," confirmed live — GLP-1 content is a secondary offering, not the platform's headline product. And a bundled program is worth pricing carefully even when part of the catalog is transparent: Metabolyz's footer discloses no legal entity name, address, or phone number anywhere, confirmed live — only a bare copyright line. A concierge model still needs a named party behind it: Mirabel Meds' LegitScript badge is self-hosted on its own infrastructure, confirmed live, and links only to LegitScript's generic homepage rather than a page that could confirm current certification. And a broad-sounding footprint deserves a second look: Modern Age's actual footprint, confirmed live through its own content, looks concentrated in the New York area, not the broad "16 states" a prior hypothesis suggested. Published pricing doesn't fix a stale legal foundation: MyDietDoc's Terms of Use is dated March 10, 2014 and its Privacy Policy May 1, 2016, confirmed live — both extremely stale for a site actively selling prescription GLP-1s today. And a bundled program's real value is worth checking against a published, itemized table: Nava Health's own /pricing page itemizes its NavaRX program by membership tier, confirmed live — $2,300 for non-members versus $1,295 for Longevity members over the same 3-month initial period. Unusually candid language is worth noticing on its own: Nuform Health's compounding disclaimer states plainly, confirmed live and verbatim, that its medications "are not FDA-approved or evaluated for safety, effectiveness, or quality". And a published state list only helps if the coverage behind it is checkable too: Omnia TeleHealth's 17-state coverage list isn't published anywhere, confirmed live — a phone call is required to confirm which states are actually included. A homepage teaser price is worth checking against the actual binding terms: Peptivo's homepage advertises "starting at $169" and "starting at $249," confirmed live, but its own binding Terms and Conditions price both drugs materially higher. And a page literally labeled "Pricing" should have some: PRIMO Health Partners publishes no pricing anywhere, confirmed live, not even on the page literally labeled "Pricing" in its own site navigation. An itemized fee is worth more than a bundled one: Reset Solutions' $99/month program fee and separate ~$70/month medication cost, confirmed live, are genuinely itemized rather than bundled into one figure. And a young company can still name real infrastructure: Risen Labs names its compounding pharmacy directly, confirmed live — Olympia Pharmacy, a 503A facility, repeated throughout the site's own code. Vague language can hide a real gap: Teladoc Health's GLP-1 program page publishes no self-pay price anywhere, confirmed live — only vague "out-of-pocket costs" language for readers without employer or health-plan access. And a specific medication name should be checkable somewhere on the site: TeleFirst Med's live public site never names a single GLP-1 drug anywhere, confirmed on this pass, despite a prior hypothesis describing a specific brand-only prescribing model. A state list in a page's own title tag is a specific, checkable claim: Rixa Health's own title tag lists 45 states "Taking Clients In," confirmed live, with five more listed as "Coming Soon". And two conflicting FAQ answers on the same page are worth reading carefully: Steady State Health's own FAQ gives two directly conflicting answers, confirmed live, about whether GLP-1 medication is bundled into its $139/month fee. A commented-out logo carousel is worth noticing even when it's not currently shown: TeleWellnessMD's homepage contains a commented-out, not-currently-displayed pharmacy-partner logo carousel naming several real compounding pharmacies, confirmed live in the code. And a brand-only prescriber is a real, checkable claim worth confirming directly: The Virtual NP prescribes only FDA-approved brand-name Zepbound and Wegovy, confirmed live, with no compounded option at all. A broad licensing footprint is a real, independently checkable credential: TRT Kingdom's CMO independently checks out as a real, active physician via the federal NPI registry, confirmed live, with an unusually broad multi-state footprint. And a real medical practice named only in the fine print is still worth knowing about: Vea Health's own Terms of Service disclose that actual medical care is delivered by a separate legal entity, Dr Telx, PLLC, confirmed live and independently verified as a real practice. Care can also be gated behind an employer benefit rather than a checkout page: Vida Health prescribes GLP-1s through employer and health-plan benefits, confirmed live, but names no individual clinician anywhere on its own site. A legal document can leak evidence of a shared template vendor: Vital Harmony Rx's own live Terms and Conditions page still contains a duplicated, un-rebranded block referencing a dead prior domain, confirmed live, the same stale-template pattern documented elsewhere on this list. And a directory hypothesis isn't always right: VivioMD does in fact offer both compounded and brand-name GLP-1 medications, confirmed live, contrary to an earlier hypothesis that it didn't. Retail pharmacy brands run real GLP-1 telehealth too, though not always on their own infrastructure: Walgreens Weight Management's booking app runs on a third-party telehealth vendor, Wheel Health, confirmed live in the app's own embedded API configuration, and WeightWatchers Clinic has quietly rebranded to "WW Med+," with GLP-1 medication billed separately from its $74-$84/month membership. A named clinical network is worth confirming even when the live site itself won't load: WellMedRx's named partners, OpenLoop Health and Mycelium Pharmacy, check out via a recent archive, though the live site returned a persistent rate-limit error to every fetch attempt this pass. And a product page can avoid naming its own drug entirely: Wellspring Longevity Clinic's dedicated GLP-1 product page never once says "semaglutide" or "tirzepatide," relying instead on euphemisms like "Appetite and Craving Control". We cover how to vet what you're buying in our guide to verifying a peptide's certificate of analysis and the vendor red flags to watch for.

For drug-tested athletes, this is also dangerous ground. GH-axis peptides, GH fragments, and metabolic modulators sit in WADA-prohibited territory, and GLP-1/incretin agents marketed for body composition are exactly the kind of substances tested athletes must scrutinize. Our guides to whether GH peptides are safe and legal and whether peptides show up on drug tests cover the compliance picture.

Bottom Line

Strip away the marketing and the "peptides for fat loss" landscape collapses to a short, honest list. One category — GLP-1 and incretin drugs — has strong randomized human fat-loss evidence, but it's prescription medicine for obesity that also costs lean mass, not a physique tool for lean athletes. One drug, tesamorelin, reduces visceral fat but only has approved evidence in a specific clinical population. The famous "fat loss fragments" (AOD-9604, HGH 176-191) failed their human trials. And the "recomp" peptides marketed to do it all run entirely on animal data — no peptide has been shown to lose fat and build muscle at once in healthy, training people.

The unglamorous truth: the most reliable recomposition strategy is still a sensible energy deficit, enough protein, and resistance training to protect your muscle — the only "stack" with strong human evidence behind it. Peptides are, at most, an addition to that foundation, and most of the popular ones don't even clear the bar of being proven. For where each of these compounds ranks on real evidence, see our evidence-ranked guide to the best recovery peptides.